| Literature DB >> 28718408 |
Yifan Meng1, Ding Ma2, Peng Wu3.
Abstract
Persistent infection with high-risk human papillomavirus (hrHPV) is a key step in the development of cervical cancer. However, making clinical decisions about how to deal with these cases has become a challenge for obstetrics and gynecology (Ob/Gyn) practitioners. Here, we review the latest research findings and propose possible solutions for the management of persistent hrHPV infections.Entities:
Keywords: biomarkers; hrHPV test; human papillomavirus (HPV); next-generation sequencing (NGS); triages
Mesh:
Year: 2017 PMID: 28718408 DOI: 10.1016/j.trecan.2017.03.010
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025